Yoshihiro Onouchi - Concepedia

Author

Yoshihiro Onouchi

Chiba University ORCID

Also Known As

Hiromichi Hamada, Hiroshi Kamiyama, Wei-Chiao Chen, Y Onouchi, Y. Onouchi, Yoshihiro ONOUCHI, Yoshihiro Onouchi

Publications

Citations

H-Index

Concepts

All Affiliations

Chiba University RIKEN Center for Integrative Medical Sciences The University of Tokyo Tokyo Women's Medical University Wakayama Medical University

About

Yoshihiro Onouchi is an author at Chiba University specializing in medicine, genetic epidemiology, and genetics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	31	2.8K
2	Public Health	11	11	1.3K
3	Allergy	3	3	87
4	Engineering	1	1	46
5	Biostatistics	1	1	52

Yoshihiro Onouchi

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms Yoshihiro Onouchi, Tomohiko Gunji, Jane C. Burns, Nature Genetics Cardiovascular DiseaseKawasaki Disease SusceptibilityGenetic EpidemiologyCoronary Artery AneurysmsPathology	2007	517
A genome-wide association study identifies three new risk loci for Kawasaki disease Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Burns, Nature Genetics Genome-wide Association StudyDisease SusceptibilityMedicineGeneticsGenetic Epidemiology	2012	334
Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn’s disease in Japanese patients Keiko Yamazaki, Yoshihiro Onouchi, Masakazu Takazoe, Journal of Human Genetics Genome-wide Association StudyAssociation AnalysisGenetic VariantsGeneticsImmunology	2007	206
Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial Hiromichi Hamada, Hiroyuki Suzuki, Yoshihiro Onouchi, The Lancet Cardiovascular DiseaseAtherosclerosisIntravenous ImmunoglobulinImmunologyMedicine	2019	202
Common variants in CASP3 confer susceptibility to Kawasaki disease Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Buns, Human Molecular Genetics ImmunodeficienciesGeneticsGenetic EpidemiologyImmunologyPathology	2010	174
Cyclosporin A Treatment for Kawasaki Disease Refractory to Initial and Additional Intravenous Immunoglobulin Hiroyuki Suzuki, Masaru Terai, Hiromichi Hamada, The Pediatric Infectious Disease Journal	2011	154
Calcineurin Inhibitor Treatment of Intravenous Immunoglobulin–Resistant Kawasaki Disease Adriana H. Tremoulet, Paige Pancoast, Alessandra Franco, The Journal of Pediatrics MedicineImmunologyTherapeutic EfficacyExperimental TherapeuticPharmacotherapy	2012	139
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan Takahiro Kageyama, Kei Ikeda, Shigeru Tanaka, Clinical Microbiology and Infection VaccinationVaccine DevelopmentTertiary Referral HospitalVaccine SurveillanceImmunology	2021	137
Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease Keiko Yamazaki, Masakazu Takazoe, Torao Tanaka, Journal of Human Genetics Association AnalysisCrohn DiseaseGenetic EpidemiologyGastroenterologyPathology	2004	124
ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease Yoshihiro Onouchi, Yoichi Suzuki, Hiroyuki Suzuki, The Pharmacogenomics Journal Cardiovascular DiseaseGenetic EpidemiologyImmunologyPathologyHuman Polymorphism	2011	123

Page 1